Tango Therapeutics Inc.
TNGX | NASDAQ
$24.10
+$1.77 (+7.93%)
Sep 22, 2026, 10:56 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 53.81M | 56.99M | 62.38M | 66.5M | 24.3M | 40.99M | 42.07M | 43.38M | 42.51M | 37.23M | 36.53M | 37.51M | 33.7M | 24.87M | 24.86M | 24.17M | 24.03M | 36.41M | 37.04M | 40.47M | 22.42M | 9.33M |
Cost of Revenue | 942K | 1.57M | 1.1M | 625K | 625K | n/a | n/a | n/a | 613K | 2.12M | 3.58M | 5.03M | 5.64M | 4.82M | 4.03M | 3.15M | 23.86M | 23.63M | 23.41M | 23.26M | 14.31M | 24.98M |
Gross Profit | 52.87M | 55.43M | 61.28M | 65.88M | 23.67M | 40.99M | 42.07M | 43.38M | 41.9M | 35.11M | 32.95M | 32.48M | 28.06M | 20.05M | 20.83M | 21.01M | 176K | 12.78M | 13.63M | 17.21M | 8.11M | -15.65M |
Operating Income | -136.35M | -117.53M | -111.29M | -110.34M | -157.29M | -145.87M | -145.6M | -139.7M | -132.45M | -126.14M | -114.17M | -109.73M | -114.02M | -115.98M | -111.07M | -102.49M | -92.13M | -71.49M | -58.19M | -45.14M | -52.33M | -56.22M |
Interest Income | 8.68M | 6.19M | 5.63M | 5.76M | 6.48M | 7.31M | 7.89M | 8.31M | 8.38M | 7.76M | 6.62M | 4.97M | 3.45M | 2.3M | 1.46M | 1.06M | 802K | 609K | 495K | 370K | 279K | 175K |
Pretax Income | -123.78M | -107.26M | -101.59M | -100.41M | -145.39M | -132.06M | -130.09M | -123.19M | -116.32M | -111.48M | -101.61M | -99.9M | -106.71M | -110.92M | -108.12M | -100.98M | -91.46M | -71.12M | -57.94M | -44.94M | -52.21M | -56.09M |
Net Income | -123.72M | -107.23M | -101.59M | -100.52M | -145.57M | -132.26M | -130.3M | -123.4M | -116.49M | -111.65M | -101.74M | -100.04M | -106.83M | -110.98M | -108.18M | -101.16M | -91.7M | -71.34M | -58.24M | -45.05M | -52.27M | -56.16M |
Selling & General & Admin | 56.51M | 45.26M | 41.51M | 42.84M | 45.13M | 44.57M | 43.75M | 41.76M | 39.14M | 36.03M | 31.92M | 29.25M | 27.54M | 26.42M | 26M | 25.05M | 22.61M | 19.23M | 16.11M | 13.21M | 11.3M | 10.51M |
Research & Development | 134.37M | 129.35M | 132.72M | 133.38M | 135.82M | 142.3M | 143.92M | 141.32M | 135.21M | 125.22M | 115.2M | 112.95M | 114.55M | 109.62M | 105.91M | 98.45M | 91.63M | 86.97M | 77.64M | 71.07M | 62.12M | 54.17M |
Other Expenses | -1.66M | -1.66M | -1.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -21.92M | -21.92M | -21.92M | -21.92M | -12.98M | -24.11M |
Operating Expenses | 189.22M | 172.95M | 172.57M | 176.21M | 180.96M | 186.86M | 187.67M | 183.08M | 174.34M | 161.25M | 147.12M | 142.2M | 142.08M | 136.03M | 131.9M | 123.5M | 92.31M | 84.27M | 71.82M | 62.35M | 60.44M | 40.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | 50K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 190.16M | 174.52M | 173.67M | 176.84M | 181.58M | 186.86M | 187.67M | 183.08M | 174.96M | 163.37M | 150.7M | 147.23M | 147.72M | 140.85M | 135.93M | 126.65M | 116.17M | 107.9M | 95.23M | 85.61M | 74.75M | 65.55M |
Income Tax Expense | -63K | -29K | 4K | 108K | 172K | 202K | 208K | 206K | 175K | 174K | 134K | 138K | 115K | 54K | 54K | 180K | 242K | 218K | 292K | 115K | 53K | 74K |
Shares Outstanding (Basic) | 149.88M | 143.58M | 116.17M | 110.97M | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 95.8M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
Shares Outstanding (Diluted) | 149.88M | 143.58M | 116.17M | 110.97M | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 95.8M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
EPS (Basic) | -0.85 | -0.83 | -0.87 | -0.91 | -1.32 | -1.21 | -1.20 | -1.18 | -1.14 | -1.13 | -1.07 | -1.08 | -1.17 | -1.22 | -1.22 | -1.14 | -1.10 | -0.87 | -0.72 | -1 | -0.72 | -1.42 |
EPS (Diluted) | -0.85 | -0.83 | -0.87 | -0.91 | -1.32 | -1.21 | -1.20 | -1.18 | -1.14 | -1.13 | -1.07 | -1.08 | -1.17 | -1.22 | -1.22 | -1.14 | -1.10 | -0.87 | -0.72 | -0.89 | -0.61 | -1.31 |
EBITDA | -122.29M | -105.14M | -99.31M | -97.99M | -142.91M | -129.57M | -127.6M | -120.69M | -113.83M | -108.11M | -97.41M | -94.87M | -101.08M | -106.11M | -104.09M | -97.83M | -89.3M | -69.19M | -56.23M | -43.38M | -50.65M | -54.86M |
EBIT | -123.78M | -107.26M | -101.59M | -100.41M | -145.39M | -132.06M | -130.09M | -123.19M | -116.32M | -111.48M | -101.61M | -99.9M | -106.71M | -110.92M | -108.12M | -100.98M | -91.46M | -71.12M | -57.94M | -44.94M | -52.17M | -56.1M |
Depreciation & Amortization | 1.5M | 2.12M | 2.28M | 2.42M | 2.49M | 2.5M | 2.5M | 2.5M | 2.49M | 3.36M | 4.2M | 5.03M | 5.64M | 4.82M | 4.03M | 3.15M | 2.16M | 1.93M | 1.71M | 1.56M | 1.52M | 1.24M |
Add to Watchlist
Select watchlists to add or remove TNGX